Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan
Update: 2024-08-01
Description
The use of real-world evidence is increasing rapidly throughout the device industry. Here we talk with Paul Coplan, who is leading that effort at J&J, which received the first FDA-approved label extension using real-world evidence. Our conversation embraces the breadth of real-world evidence uses, including the recent FDA guidance, as well as global applications of real-world evidence, and its use in emerging areas like health equity and AI.
Comments
In Channel





